News

Published on 13 Nov 2024 on GuruFocus.com · via Yahoo Finance

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight


Article preview image

Comprehensive SWOT analysis reveals Gilead Sciences Inc's strategic positioning in the...

NASDAQ.GILD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight

Comprehensive SWOT analysis reveals Gilead Sciences Inc's strategic positioning in the...

GuruFocus.com · via Yahoo Finance 13 Nov 2024

HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported...

Benzinga · via Yahoo Finance 7 Nov 2024

Gilead Sciences Inc (GILD) Q3 2024 Earnings Call Highlights: Strong HIV and...

Gilead Sciences Inc (GILD) reports robust Q3 performance with significant gains in HIV and oncolo...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported...

Benzinga · via AOL 7 Nov 2024

Gilead Sciences' chief medical officer sells $2.34 million in stock By...

In recent activity reported by Gilead Sciences, Inc. (NASDAQ:GILD), Chief Medical (TASE:PMCN)...

Investing.com 7 Nov 2024

Gilead’s earnings beat by a wide margin, and biotech raises guidance

Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew p...

Market Watch 6 Nov 2024

Is Gilead Sciences, Inc. (GILD) the Best Pharma Stock to Buy Right Now?

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 4 Nov 2024

SAP BrandVoice: Drug Shortages Create Surprising Opportunity For Pharma Supply...

Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains,...

Forbes 22 Oct 2024

Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows...

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new...

Benzinga · via Yahoo Finance 21 Oct 2024

Goldman Sachs: Gilead Sciences, Inc. (NASDAQ:GILD) Is A Stock With High...

We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The...

Insider Monkey · via Yahoo Finance 19 Oct 2024